- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Brain alpha‐amylase: a novel energy regulator important in Alzheimer disease?
-
- Elin Byman
- Clinical Memory Research Unit, Department of Clinical Sciences Malmö Lund University Malmö Sweden
-
- Nina Schultz
- Clinical Memory Research Unit, Department of Clinical Sciences Malmö Lund University Malmö Sweden
-
- Malin Fex
- Unit for Molecular Metabolism, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University Malmö Sweden
-
- Malin Wennström
- Clinical Memory Research Unit, Department of Clinical Sciences Malmö Lund University Malmö Sweden
Search this article
Description
<jats:title>Abstract</jats:title><jats:p>Reduced glucose metabolism and formation of polyglucosan bodies (PGB) are, beside amyloid beta plaques and neurofibrillary tangles, well‐known pathological findings associated with Alzheimer's disease (AD). Since both glucose availability and PGB are regulated by enzymatic degradation of glycogen, we hypothesize that dysfunctional glycogen degradation is a critical event in AD progression. We therefore investigated whether alpha (α)‐amylase, an enzyme known to efficiently degrade polysaccharides in the gastrointestinal tract, is expressed in the hippocampal CA1/subiculum and if the expression is altered in AD patients. Using immunohistochemical staining techniques, we show the presence of the α‐amylase isotypes AMY1A and AMY2A in neuronal dendritic spines, pericytes and astrocytes. Moreover, AD patients showed reduced gene expression of α‐amylase, but conversely increased protein levels of α‐amylase as well as increased activity of the enzyme compared with non‐demented controls. Lastly, we observed increased, albeit not significant, load of periodic acid‐Schiff positive PGB in the brain of AD patients, which correlated with increased α‐amylase activity. These findings show that α‐amylase is expressed and active in the human brain, and suggest the enzyme to be affected, alternatively play a role, in the neurodegenerative Alzheimer's disease pathology.</jats:p>
Journal
-
- Brain Pathology
-
Brain Pathology 28 (6), 920-932, 2018-03-30
Wiley
- Tweet
Details 詳細情報について
-
- CRID
- 1363107369958872576
-
- ISSN
- 17503639
- 10156305
-
- Data Source
-
- Crossref